These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36162481)

  • 1. How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock.
    Teja B; Bosch NA; Walkey AJ
    Chest; 2023 Mar; 163(3):567-574. PubMed ID: 36162481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
    Bosch NA; Teja B; Wunsch H; Walkey AJ
    Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
    [No Abstract]   [Full Text] [Related]  

  • 3. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The initial resuscitation of septic shock.
    Cinel I; Kasapoglu US; Gul F; Dellinger RP
    J Crit Care; 2020 Jun; 57():108-117. PubMed ID: 32135409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies in Corticosteroid use for Sepsis.
    Long B; Koyfman A
    J Emerg Med; 2017 Nov; 53(5):653-661. PubMed ID: 28916121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension Across Michigan Hospitals: A Retrospective Cohort Study.
    Munroe ES; Heath ME; Eteer M; Gershengorn HB; Horowitz JK; Jones J; Kaatz S; Tamae Kakazu M; McLaughlin E; Flanders SA; Prescott HC
    Chest; 2024 Apr; 165(4):847-857. PubMed ID: 37898185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
    Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
    J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Review of Vasopressors in Emergency Medicine.
    Stampfl M; DeBlieux P
    J Emerg Med; 2024 Jul; 67(1):e31-e41. PubMed ID: 38789351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressor weaning in patients with septic shock.
    Arellano DL; Hanneman SK
    Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study.
    Teja B; Bosch NA; Wijeysundera DN; Wijeysundera HC; Saskin R; Hill AD; Stelfox HT; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2022 Oct; 19(10):1713-1721. PubMed ID: 35709214
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The definition of septic shock: implications for treatment.
    Marik PE; Lipman J
    Crit Care Resusc; 2007 Mar; 9(1):101-3. PubMed ID: 17352674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock.
    Whitson MR; Mo E; Nabi T; Healy L; Koenig S; Narasimhan M; Mayo PH
    Chest; 2016 Jun; 149(6):1380-3. PubMed ID: 26953217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
    Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
    Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
    Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
    JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
    Jeon K; Song JU; Chung CR; Yang JH; Suh GY
    Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Vasopressors Be Started Early in Septic Shock?
    Cioccari L; Jakob SM; Takala J
    Semin Respir Crit Care Med; 2021 Oct; 42(5):683-688. PubMed ID: 34544185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is vasopressin an ideal vasopressor to treat hypotension in septic shock?
    Romand JA; Treggiari-Venzi M
    Intensive Care Med; 1999 Jul; 25(7):763-4. PubMed ID: 10577013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.